A toxicokinetic study of inhaled ethylene glycol ethyl ether acetate and validation of a physiologically based pharmacokinetic model for rat and human

Toxicology and Applied Pharmacology

Volumn 165, Issue 1, 2000, Pages 63-73

  Gargas, Michael L ^a   Tyler, Tipton R ^b   Sweeney, Lisa M ^a   Corley, Richard A ^c   Weitz, Karl K ^c   Mast, Terryl J ^c   Paustenbach, Dennis J ^d   Hays, Sean M ^a  

^a ChemRisk Division of McLaren/Hart Environmental Engineering   (United States)

^b UNION CARBIDE CORPORATION   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^d EXPONENT INC   (United States)

Author keywords

Ethoxyacetic acid (EAA); Ethylene glycol monoethyl ether (EGEE); Ethylene glycol monoethyl ether acetate (EGEEA); Physiologically based pharmacokinetic (PBPK) model

Indexed keywords

ETHYLENE GLYCOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FEMALE; HUMAN; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; RAT; TOXICITY TESTING; TOXICOKINETICS; VALIDATION PROCESS;

ANIMALIA; RODENTIA;

EID: 0034658004     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2000.8927     Document Type: Article

References (51)

1. American Conference of Governmental Industrial Hygienists (ACGIH), 1991, Documentation of the Threshold Limit Values and Biological Exposure Indices. 6th ed, ACGIH, Cincinnati, OH.
2. American Conference of Governmental Industrial Hygienists (ACGIH), 1999, 1999 TLVs and BEIs; Threshold Limit Values for Chemical Substances and Physical Agents Biological Exposure Indices, ACGIH, Cincinnati, OH.
3. Andersen M. E., Clewell H. J. III, Gargas M. L., MacNaughton M. G., Reitz R. H., Nolan R. J., McKenna M. J. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans. Toxicol. Appl. Pharmacol. 108:1991;14-27.
4. Andrew F. D., Hardin B. D. Developmental effects after inhalation exposure of gravid rabbits and rats to ethylene glycol monoethyl ether. Environ. Health Perspect. 57:1984;13-23.
5. Barbee S. J., Terrill J. B., DeSousa D. J., Conaway C. C. Subchronic inhalation toxicology of ethylene glycol monoethyl ether in the rat and rabbit. Environ. Health Perspect. 57:1984;157-163.
6. Cheever K. L., Plotnick H. B., Richards D. E., Weigel W. W. Metabolism and excretion of 2-ethoxyethanol in the adult male rat. Environ. Health Perspect. 57:1984;241-248.
7. Clarke D. O., Elswick B. A., Welsch F., Conolly R. B. Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: A physiologically based mathematical model. Toxicol. Appl. Pharmacol. 121:1993;239-252.
8. Corley R. A., Bormett G. A., Ghanayem B. I. Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans. Toxicol. Appl. Pharmacol. 129:1994;61-79.
9. Dedrick R. L. Animal scale-up. J. Pharmacokin. Biopharm. 1:1973;435-461.
10. Doe J. E. Ethylene glycol monoethyl ether and ethylene glycol monoethyl ether acetate teratology studies. Environ. Health Perspect. 57:1984;33-41.
11. Fisher J. W., Whittaker T. A., Taylor D. H., Clewell H. J. III, Andersen M. E. Physiologically based pharmacokinetic modeling of the pregnant rat: A multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol. Appl. Pharmacol. 99:1989;395-414.
12. Foster P. M., Creasy D. M., Foster J. R., Gray T. J. Testicular toxicity produced by ethylene glycol monomethyl and monoethyl ethers in the rat. Environ. Health Perspect. 57:1984;207-217.
13. Gargas M. L., Tyler T. R., Sweeney L. M., Corley R. A., Weitz K. K., Mast T. J., Paustenbach D. J., Hays S. M. A toxicokinetic study of inhaled ethylene glycol monomethyl ether (2-ME) and validation of a physiologically based pharmacokinetic model for the pregnant rat and human. Toxicol. Appl. Pharmacol. 165:2000;53-62.
14. Gerde P., Dahl A. A model for the uptake of inhaled vapors in the nose of the dog during cyclic breathing. Toxicol. Appl. Pharmacol. 109:1991;276-288.
15. Green C., Gordon G., Cohen P., Nolen H., Peters J., Tyson C. In vitro metabolism of glycol ethers by human and rat hepatocytes. Occup. Hyg. 2:1996;67-75.
16. Groeseneken D., Veulemans H., Masschelein R. Respiratory uptake and elimination of ethylene glycol monoethyl ether after experimental human exposure. Br. J. Ind. Med. 43:1986a;544-549.
17. Groeseneken D., Veulemans H., Masschelein R. Urinary excretion of ethoxyacetic acid after experimental human exposure to ethylene glycol monoethyl ether. Br. J. Ind. Med. 43:1986b;615-619.
18. Groeseneken D., Veulemans H., Masschelein R., Van Vlem E. Ethoxyacetic acid: A metabolite of ethylene glycol monoethyl ether acetate in man. Br. J. Ind. Med. 44:1987a;488-493.
19. Groeseneken D., Veulemans H., Masschelein R., Van Vlem E. Pulmonary absorption and elimination of ethylene glycol monoethyl ether acetate in man. Br. J. Ind. Med. 44:1987b;309-316.
20. Groeseneken D., Veulemans H., Masschelein R., Van Vlem E. Comparative urinary excretion of ethoxyacetic acid in man and rat after single low doses of ethylene glycol monoethyl ether. Toxicol. Lett. 41:1988;57-68.
21. Guest D., Hamilton M. L., Deisinger P. J., DiVincenzo G. D. Pulmonary and percutaneous absorption of 2-propoxyethyl acetate and 2-ethoxyethyl acetate in beagle dogs. Environ. Health Perspect. 57:1984;177-183.
22. Hanley T. R. Jr., Yano B. L., Nitschke K. D., John J. A. Comparison of the teratogenic potential of inhaled ethylene glycol monomethyl ether in rats, mice, and rabbits. Toxicol. Appl. Pharmacol. 75:1984;409-422.
23. Hardin B. D., Niemeier R. W., Smith R. J., Kuczuk M. H., Mathinos P. R., Weaver T. F. Teratogenicity of 2-ethoxyethanol by dermal application. Drug Chem. Toxicol. 5:1982;277-294.
24. Hays S. M., Elswick B. A., Blumenthal G. M., Welsch F., Conolly R. B., Gargas M. L. Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats. Toxicol. Appl. Pharmacol. 163:2000;67-74.
25. Hays S. M., Long T. M., Kirman C. R., Gargas M. L. Potential uses of PBPK modeling to improve the regulation of exposure to toxic compounds. Inside EPA's Risk Policy Report. 5:1998;37-41.
26. International Commission on Radiological Protection (ICRP), 1975, Report of the Task Group on Reference Man. ICRP No. 23, Pergamon Press, Elmsford, New York.
27. Johanson G. Modelling of respiratory exchange of polar solvents. Am. Occup. Hyg. 35:1991;323-339.
28. Johanson G., Dynesius B. Liquid/air partition coefficients of six commonly used glycol ethers. Br. J. Ind. Med. 45:1988;561-564.
29. Kalf G., Post G., Snyder R. Solvent toxicology: Recent advances in the toxicology of benzene, the glycol ethers, and carbon tetrachloride. Annu. Rev. Pharmacol. Toxicol. 27:1987;399-427.
30. Kennedy C. H., Bechtold W. E., Chang I. Y., Henderson R. F. Effect of dose on the disposition of 2-ethoxyethanol after inhalation by F344/N rats. Fundam. Appl. Toxicol. 21:1993;486-491.
31. Kezic S., Mahieu K., Monster A. C., de Wolff F. A. Dermal absorption of vaporous and liquid 2-methoxyethanol and 2-ethoxyethanol in volunteers. Occup. Environ. Med. 54:1997;38-43.
32. Knight C. H., Docherty A. H., Peaker M. Milk yield in rats in relation to activity and size of the mammary secretory cell population. J. Dairy Res. 51:1984;29-35.
33. Krishnan K., Andersen M. E. Interspecies scaling in pharmacokinetics. Rescigno A., Thakur A. K. New Trends in Pharmacokinetics. 1991;Plenum Press, New York.
34. Luecke R. H., Wosilait W. D., Pearce B. A., Young J. F. A physiologically based pharmacokinetic computer model for human pregnancy. Teratology. 49:1994;90-103.
35. Medinsky M., Kimbell J., Morris J., Gerde P., Overton J. Symposium overview: Advances in biologically based models for respiratory tract uptake of inhaled volatiles. Fundam. Appl. Toxicol. 20:1993;265-272.
36. Medinsky M. A., Singh G., Bechtold W. E., Bond J. A., Sabourin P. J., Birnbaum L. S., Henderson R. F. Disposition of three glycol ethers administered in drinking water to male F344/N rats. Toxicol. Appl. Pharmacol. 102:1990;443-455.
37. Metcalfe J., Stock M. K., Barron D. H. Maternal physiology during gestation. Knobil E., Neill J. D. Physiology of Reproduction. 1988;2145-2176 Raven Press, New York.
38. Nagano K. E., Nakayama E., Koyano M., Oobayashi H., Adachi H., Yamada T. Testicular atrophy of mice induced by ethylene glycol monoalkyl ethers. Jpn. J. Ind. Health. 21:1979;29-35.
39. Nelson B. K., Brightwell W. S., Setzer J. V. Reproductive toxicity of the industrial solvent 2-ethoxyethanol in rats and interactive effects of ethanol. Environ. Health Perspect. 57:1984;255-259.
40. NIOSH, 1997, NIOSH pocket guide to chemical hazards, U.S. Department of Health and Human Services, Washington, D.C.
41. 29 CFR Part 1910. 58:1993;15526-15632.
42. Paustenbach D. J. Assessment of the development risks resulting from occupational exposure to select glycol ethers within the semi-conductor industry. J. Toxicol. Env. Health. 23:1988;53-96.
43. Sabourin P. J., Medinsky M. A., Thurmond F., Birnbaum L. S., Henderson R. F. Effect of dose on the disposition of methoxyethanol, ethoxyethanol, and butoxyethanol administered dermally to male F344/N rats. Fundam. Appl. Toxicol. 19:1992;124-132.
44. Seglen P. O. Preparation of isolated rat liver cells. Methods Cell Biol. 13:1976;29-84.
45. Sleet R. B., Welsch F., Myers C. B., Marr M. C. Developmental phase specificity and dose-response effects of 2-methoxyethanol in rats. Fundam. Appl. Toxicol. 29:1996;131-139.
46. Steiner, E. C, Rey, T. D, and, McCroskey, P. S. 1990, Reference Guide: SimuSolv Modeling and Simulation Software, Dow Chemical Company, Midland, MI.
47. Stott W. T., McKenna M. J. Hydrolysis of several glycol ether acetates and acrylate esters by nasal mucosal carboxylesterase in vitro. Fundam. Appl. Toxicol. 5:1985;399-404.
48. Terry K., Elswick B., Welsch F., Conolly R. Development of a physiologically based pharmacokinetic model describing 2-methoxyacetic acid disposition in the pregnant mouse. Toxicol. Appl. Pharmacol. 132:1995;103-114.
49. Tyson, C, Green, C, and, Peters, J. 1989, Method Development To Assess Human Metabolism of Chemical Xenobiotics, SRI International, Menlo Park, CA.
50. Union Carbide, 1984, A Teratologic Evaluation of CELLOSOLVE Acetate in Fischer 344 Rats and New Zealand White Rabbits Following Inhalation Exposure, Bushy Run Research Center, Export, PA, Project Report 47-116.
51. Welsch F., Blumenthal G. M., Conolly R. B. Physiologically based pharmacokinetic models applicable to organogenesis: Extrapolation between species and potential use in prenatal toxicity risk assessments. Toxicol. Lett. 82-83:1995;539-547.